ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

41,491Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 6645

$3.83M Total Retail Price of All Prescriptions

Rank: 13 out of 6645

863 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 863 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 863 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 40,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,627 1,592 1 2
ALENDRONATE SODIUM 1,273 1,266 2 14
CRESTOR 1,258 1,246 3 34
MELOXICAM 980 972 4 46
LIDODERM 966 963 5 53
LOSARTAN POTASSIUM 927 920 6 12
EVISTA 926 925 7 90
ATORVASTATIN CALCIUM 908 887 8 10
CELEBREX 898 897 9 54
NEXIUM 880 877 10 40
ACTONEL 862 862 10 11 92
SIMVASTATIN 793 779 12 1
OMEPRAZOLE 759 750 13 6
DIOVAN 726 714 14 19
AVODART 667 661 15 99
TAMSULOSIN HCL 655 628 16 22
ZOLPIDEM TARTRATE 654 639 17 17
LOVAZA 574 568 18 68
AMMONIUM LACTATE 484 480 19 266
NASONEX 479 477 10 20 126
BETAMETHASONE DIPROPIONATE 473 468 10 21 289
DEXILANT 470 464 22 102
ACETAMINOPHEN-CODEINE 463 433 S3 23 80
CLOPIDOGREL 448 448 24 36
GABAPENTIN 416 408 25 18
BYSTOLIC 404 394 26 110
PATANOL 400 399 27 131
BENICAR 378 377 28 84
JANUMET 377 374 29 132
METFORMIN HCL 373 354 30 7
LEVOTHYROXINE SODIUM 366 365 31 4
PATADAY 352 350 32 183
SURE COMFORT ALCOHOL 339 329 10 33 250
AMOXICILLIN 336 332 34 107
ATENOLOL 324 322 35 8
DONEPEZIL HCL 323 323 36 27
PLAVIX 318 318 37 49
JANUVIA 315 310 38 38
BACLOFEN 303 303 39 100
FENOFIBRATE 303 294 39 74
LIPITOR 303 301 39 69
CYMBALTA 299 282 42 78
POLYETHYLENE GLYCOL 3350 290 287 43 121
FINASTERIDE 287 265 44 73
SPIRIVA 278 278 45 65
PANTOPRAZOLE SODIUM 278 278 45 29
RESTASIS 265 265 47 311
ACIPHEX 254 254 48 167
AZELASTINE HCL 248 246 49 341
SINGULAIR 244 244 50 76
ADVAIR DISKUS 242 242 51 45
ISOSORBIDE MONONITRATE ER 239 239 52 66
VESICARE 236 236 53 148
METOPROLOL SUCCINATE 225 225 54 24
CARVEDILOL 223 219 55 25
FAMOTIDINE 221 202 56 33
GLIMEPIRIDE 220 200 57 47
NAMENDA 203 203 58 41
IBANDRONATE SODIUM 201 201 59 147
MONTELUKAST SODIUM 201 198 59 128
PROCTOZONE-HC 197 197 61 243
TRIAMCINOLONE ACETONIDE 194 193 62 55
TRAZODONE HCL 190 189 63 60
METFORMIN HCL ER 185 181 64 89
PAROXETINE HCL 173 173 65 72
FLUOXETINE HCL 171 171 66 63
GLYBURIDE-METFORMIN HCL 169 163 R 67 95
URSODIOL 161 150 68 349
MICARDIS 160 159 69 232
ESCITALOPRAM OXALATE 156 154 70 86
EXELON 153 152 71 149
ALLOPURINOL 152 135 72 31
CREON 151 151 73 114
TRICOR 147 143 74 138
PRAMIPEXOLE DIHYDROCHLORIDE 140 139 75 222
FUROSEMIDE 136 136 76 11
VOLTAREN 133 132 77 108
LISINOPRIL 130 122 78 3
FLUTICASONE PROPIONATE 129 124 79 26
AZOR 125 125 80 152
TRILIPIX 122 122 81 178
AMLODIPINE BESYLATE-BENAZEPRIL 122 122 81 97
ATELVIA 118 118 83 91
QUETIAPINE FUMARATE 117 109 84 101
DIGOXIN 117 117 84 59
NIFEDIPINE ER 113 112 86 82
SYMBICORT 111 111 87 153
BENAZEPRIL HCL 105 103 88 21
ONGLYZA 105 105 88 168
SOLARAZE 103 102 90 394
BONIVA 97 97 91 191
PRADAXA 96 96 92 247
SOTALOL 93 93 93 332
EXFORGE 91 91 94 155
GALANTAMINE HBR 90 90 95 400
LEXAPRO 88 88 96 218
CLOTRIMAZOLE-BETAMETHASONE 88 84 96 177
RANEXA 87 87 98 276
ZETIA 87 86 98 87
MEGACE ES 86 83 R 100 382
POTASSIUM CHLORIDE 85 85 101 28
AZITHROMYCIN 84 83 102 44
VYTORIN 83 83 103 170
ECONAZOLE NITRATE 77 75 104 263
HYDROCODONE-ACETAMINOPHEN 76 74 S3 105 5
FLUOCINONIDE 76 72 105 130
AMIODARONE HCL 75 75 107 160
CARISOPRODOL 73 62 R 108 94
AMITIZA 72 72 109 245
AGGRENOX 72 66 109 282
SEROQUEL 71 68 111 208
ACTOS 71 67 111 71
LYRICA 71 69 111 127
DILTIAZEM 24HR ER 70 70 114 187
LOPERAMIDE 70 70 114 281
ANTARA 68 68 116 361
PATANASE 67 61 117 427
ISOSORBIDE DINITRATE 66 66 118 200
KOMBIGLYZE XR 66 66 118 297
RANITIDINE HCL 66 65 118 51
CIPRODEX 64 60 121 515
LEVOFLOXACIN 64 62 121 83
RIVASTIGMINE 62 62 123 363
COLCRYS 62 56 123 192
ZOSTAVAX 61 56 125 115
LEVOCETIRIZINE DIHYDROCHLORIDE 60 60 126 241
TERBINAFINE HCL 60 60 126 471
WELCHOL 57 57 128 199
ENABLEX 57 57 128 301
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 130 62
CALCITRIOL 55 55 131 205
BARACLUDE 54 54 132 432
VIGAMOX 54 52 132 574
LATANOPROST 54 54 132 320
EFFIENT 54 54 132 261
NAPHAZOLINE HCL 53 53 136 215
MEGESTROL ACETATE 52 52 R 137 104
WARFARIN SODIUM 51 46 138 16
PREDNISONE 51 49 138 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.